Results 111 to 120 of about 34,850 (241)
Arthritis &Rheumatology, Volume 78, Issue 6, Page 1196-1205, June 2026.Interlukin‐5 (IL‐5) plays a crucial role in the pathogenesis of eosinophilic granulomatosis with polyangiitis (EGPA) by promoting eosinophil differentiation, activation, and survival. We present here a typical case of EGPA in which treatment with IL‐5 pathway inhibitors is prescribed, showing to be beneficial for the patient.
Alvise Berti, Christian Pagnoux
wiley +1 more source
Acute esophageal tear in eosinophilic esophagitis
Oxford Medical Case Reports, 2021 Föh, Bandik +3 more
openaire +2 more sources
Clinical and Translational Allergy, Volume 16, Issue 6, June 2026.ABSTRACT Background Multiple routes of allergen immunotherapy (AIT) are approved for several IgE‐mediated allergic diseases; however, the use of AIT in eosinophilic esophagitis (EoE) remains controversial and is supported by limited evidence. This review, conducted within the frame of an EAACI Task Force, aims to systematically evaluate the use of AIT ...
Martina Votto +17 more
wiley +1 more source
Clinical and Translational Allergy, Volume 16, Issue 6, June 2026.This review positions skin tape stripping as a methodological bridge in atopic dermatitis, linking epidermal molecular profiling with systemic inflammation. Integrated with multi‐omics technologies, STS enables non‐invasive biomarker discovery, disease endotyping, and treatment monitoring, advancing precision medicine for AD. ABSTRACT Atopic dermatitis
Ziyuan Tian, Ke Xue, Yong Cui
wiley +1 more source
The Esophageal Microbiome in Eosinophilic Esophagitis [PDF]
Gastroenterology, 2016 openaire +2 more sources
Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1555-1564, June 2026.Dupilumab, a fully human monoclonal antibody that blocks key drivers of type 2 inflammation, is approved across 8 diseases, including eosinophilic esophagitis. Subcutaneous dupilumab 300 mg weekly improved outcomes vs. placebo in adults (aged ≥ 18 years) and adolescents (aged ≥ 12 to < 18 years) during the phase III LIBERTY EoE TREET study (NCT03633617)
Jenny‐Hoa Nguyen +8 more
wiley +1 more source
Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal +7 more
wiley +1 more source
Intramural Esophageal Hematoma with Herpes Esophagitis
Internal Medicine, 2022 Takemoto, Kiyoshi, Atagi, Kazuaki
openaire +3 more sources
International Journal of Cancer, Volume 158, Issue 11, Page 2822-2828, 1 June 2026.What's new? Esophageal squamous cell carcinoma (ESCC) incidence varies worldwide, suggesting that local environmental and dietary factors are influential. In coastal southeastern China, food products derived from small filter‐feeding fish are important dietary components, though their consumption increased ESCC risk.
Haisheng Wu +10 more
wiley +1 more source
Esophageal Atresia and Tracheo-Esophageal Fistula
Plastic and Reconstructive Surgery, 1947 W E, Ladd, O, Swenson
openaire +3 more sources